|
|
News Breaks
|
November 16, 2009
|
| 07:23 EDT |  | CERS |
| theflyonthewall.com: | The FDA Blood Products Advisory Committee to hold a meeting | | Two day meeting of the FDA's Blood Products Advisory Committee will be held in Bethesda, Maryland on November 16-17. On Day One, the committee hears updates on HHS Advisory Committee on Blood Safety and Availability, Dengue virus outbreak, 2009 A/H1N1 Pandemic and impact on blood safety and availability. The Committee discusses blood donor deferral for malaria risk associated with travel to Mexico and the design of a new Phase III study of pathogen inactivation of human platelets using Cerus Corp's INTERCEPT Blood system. The meeting will be held on November 16 at 8 am. Webcast Link :theflyonthewall.com |
|
|
News For CERS From The Last 14 Days Check below for free stories on CERS the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 1, 2012
|
| 08:33 EDT |  | CERS |
| theflyonthewall.com: | Cerus, Ilex BioTech report INTERCEPT system approvals in Israel | | Cerus Corporation and Ilex BioTech Ltd. announced that the INTERCEPT Blood System has received regulatory approval in Israel for the treatment of platelets and plasma intended for transfusion. The INTERCEPT Blood System is designed to provide increased protection from a broad range of transfusion-transmitted pathogens, including bacteria and emerging pathogens such as the dengue and chikungunya viruses. :theflyonthewall.com |
|
|
|
|
|
